3M CO Revenue from Contract with Customer, Excluding Assessed Tax
3M CO (MMM) reported Revenue from Contract with Customer, Excluding Assessed Tax of $6.50 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-21
- 3M CO revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $6.50B, a 2.46% increase year-over-year.
- 3M CO revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $6.03B, a 1.28% increase year-over-year.
- 3M CO revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $6.13B, a 2.05% increase year-over-year.
- 3M CO revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $6.52B, a 3.54% increase year-over-year.
- 3M CO revenue from contract with customer, excluding assessed tax for fiscal 2025 was $24.95B, a 1.52% increase from fiscal 2024.
- 3M CO revenue from contract with customer, excluding assessed tax for fiscal 2024 was $24.57B, a 0.14% decline from fiscal 2023.
- 3M CO revenue from contract with customer, excluding assessed tax for fiscal 2023 was $24.61B, a 5.93% decline from fiscal 2022.
- 3M CO revenue from contract with customer, excluding assessed tax for fiscal 2022 was $26.16B, a 26.00% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.50B 10-Q · filed 2026-07-21 | $12.53B 10-Q · filed 2026-07-21 | $18.66B derived: sum of 3 quarters · filed 2026-07-21 | $25.18B derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | $6.03B 10-Q · filed 2026-04-21 | $12.16B derived: sum of 2 quarters · filed 2026-04-21 | $18.68B derived: sum of 3 quarters · filed 2026-04-21 | $25.02B derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $6.13B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $12.65B derived: sum of 2 quarters · filed 2026-02-03 | $18.99B derived: sum of 3 quarters · filed 2026-07-21 | $24.95B 10-K · filed 2026-02-03 | |
| 2025-09-30 | $6.52B 10-Q · filed 2025-10-21 | $12.86B derived: sum of 2 quarters · filed 2026-07-21 | $18.82B 10-Q · filed 2025-10-21 | $24.82B derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $6.34B 10-Q · filed 2026-07-21 | $12.30B 10-Q · filed 2026-07-21 | $18.31B derived: sum of 3 quarters · filed 2026-07-21 | $24.60B derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | $5.95B 10-Q · filed 2026-04-21 | $11.96B derived: sum of 2 quarters · filed 2026-04-21 | $18.26B derived: sum of 3 quarters · filed 2026-04-21 | $24.51B derived: sum of 4 quarters · filed 2026-04-21 | |
| 2024-12-31 | $6.01B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $12.30B derived: sum of 2 quarters · filed 2026-02-03 | $18.56B derived: sum of 3 quarters · filed 2026-02-03 | $24.57B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $6.29B 10-Q · filed 2025-10-21 | $12.55B derived: sum of 2 quarters · filed 2025-10-21 | $18.57B 10-Q · filed 2025-10-21 | $24.57B derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $6.25B 10-Q · filed 2025-07-18 | $12.27B 10-Q · filed 2025-07-18 | $18.27B derived: sum of 3 quarters · filed 2026-02-03 | $24.54B derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $6.02B 10-Q · filed 2025-04-22 | $12.02B derived: sum of 2 quarters · filed 2026-02-03 | $18.29B derived: sum of 3 quarters · filed 2026-02-03 | $24.57B derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $6.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $12.27B derived: sum of 2 quarters · filed 2026-02-03 | $18.55B derived: sum of 3 quarters · filed 2026-02-03 | $24.61B 10-K · filed 2026-02-03 | |
| 2023-09-30 | $6.27B 10-Q · filed 2024-10-22 | $12.55B derived: sum of 2 quarters · filed 2024-10-22 | $18.61B 10-Q · filed 2024-10-22 | ||
| 2023-06-30 | $6.28B 10-Q · filed 2024-07-26 | $12.34B 10-Q · filed 2024-07-26 | |||
| 2022-12-31 | $26.16B 10-K · filed 2025-02-05 | $34.23B 10-K · filed 2023-02-08 | |||
| 2021-12-31 | $35.35B 10-K · filed 2023-02-08 | ||||
| 2021-06-30 | $8.95B 10-Q · filed 2021-07-27 | $17.80B 10-Q · filed 2021-07-27 | $26.38B derived: sum of 3 quarters · filed 2021-07-27 | $34.73B derived: sum of 4 quarters · filed 2021-07-27 | |
| 2021-03-31 | $8.85B 10-Q · filed 2021-04-27 | $17.43B derived: sum of 2 quarters · filed 2021-04-27 | $25.78B derived: sum of 3 quarters · filed 2021-04-27 | $32.96B derived: sum of 4 quarters · filed 2021-07-27 | |
| 2020-12-31 | $8.58B 10-K · filed 2021-02-04 | $16.93B derived: sum of 2 quarters · filed 2021-02-04 | $24.11B derived: sum of 3 quarters · filed 2021-07-27 | $32.18B 10-K · filed 2023-02-08 | |
| 2020-09-30 | $8.35B 10-K · filed 2021-02-04 | $15.53B derived: sum of 2 quarters · filed 2021-07-27 | $23.60B 10-Q · filed 2020-10-27 | $31.71B derived: sum of 4 quarters · filed 2021-07-27 | |
| 2020-06-30 | $7.18B 10-Q · filed 2021-07-27 | $15.25B 10-Q · filed 2021-07-27 | $23.36B derived: sum of 3 quarters · filed 2021-07-27 | $31.35B derived: sum of 4 quarters · filed 2021-07-27 | |
| 2020-03-31 | $8.07B 10-Q · filed 2021-04-27 | $16.19B derived: sum of 2 quarters · filed 2021-04-27 | $24.18B derived: sum of 3 quarters · filed 2021-04-27 | $32.35B derived: sum of 4 quarters · filed 2021-04-27 | |
| 2019-12-31 | $8.11B 10-K · filed 2021-02-04 | $16.10B derived: sum of 2 quarters · filed 2021-02-04 | $24.27B derived: sum of 3 quarters · filed 2021-02-04 | $32.14B 8-K · filed 2022-04-26 | |
| 2019-09-30 | $7.99B 10-K · filed 2021-02-04 | $16.16B derived: sum of 2 quarters · filed 2021-02-04 | $24.02B 10-Q · filed 2020-10-27 | $31.97B derived: sum of 4 quarters · filed 2021-02-04 | |
| 2019-06-30 | $8.17B 10-K · filed 2021-02-04 | $16.03B 10-Q · filed 2020-07-28 | $23.98B derived: sum of 3 quarters · filed 2021-02-04 | $32.13B derived: sum of 4 quarters · filed 2021-02-04 | |
| 2019-03-31 | $7.86B 10-K · filed 2021-02-04 | $15.81B derived: sum of 2 quarters · filed 2021-02-04 | $23.96B derived: sum of 3 quarters · filed 2021-02-04 | $32.35B derived: sum of 4 quarters · filed 2021-02-04 | |
| 2018-12-31 | $7.95B 10-K · filed 2020-02-06 | $16.10B derived: sum of 2 quarters · filed 2020-02-06 | $24.49B derived: sum of 3 quarters · filed 2020-02-06 | $32.77B 10-K · filed 2021-02-04 | |
| 2018-09-30 | $8.15B 10-K · filed 2020-02-06 | $16.54B derived: sum of 2 quarters · filed 2020-02-06 | $24.82B 10-Q · filed 2019-10-25 | $32.81B derived: sum of 4 quarters · filed 2020-02-06 | |
| 2018-06-30 | $8.39B 10-K · filed 2020-02-06 | $16.67B 10-Q · filed 2019-07-26 | $24.66B derived: sum of 3 quarters · filed 2020-02-06 | $32.83B derived: sum of 4 quarters · filed 2020-02-06 | |
| 2018-03-31 | $8.28B 10-K · filed 2020-02-06 | $16.27B derived: sum of 2 quarters · filed 2020-02-06 | $24.44B derived: sum of 3 quarters · filed 2020-02-06 | $32.25B derived: sum of 4 quarters · filed 2020-02-06 | |
| 2017-12-31 | $7.99B 10-K · filed 2019-02-07 | $16.16B derived: sum of 2 quarters · filed 2019-02-07 | $23.97B derived: sum of 3 quarters · filed 2019-02-07 | $31.66B 10-K · filed 2019-02-07 | |
| 2017-09-30 | $8.17B 10-K · filed 2019-02-07 | $15.98B derived: sum of 2 quarters · filed 2019-02-07 | $23.67B derived: sum of 3 quarters · filed 2019-02-07 | ||
| 2017-06-30 | $7.81B 10-K · filed 2019-02-07 | $15.49B derived: sum of 2 quarters · filed 2019-02-07 | |||
| 2017-03-31 | $7.68B 10-K · filed 2019-02-07 | ||||
| 2016-12-31 | $30.11B 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |